{"title":"Coming Up…","authors":"","doi":"10.1002/adaw.34544","DOIUrl":"https://doi.org/10.1002/adaw.34544","url":null,"abstract":"<p>The <b>CPDD annual meeting</b> will be held <b>June 14-18</b> in New Orleans. For more information, go to https://cpdd.org/meetings/current-meeting/</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"DEA assesses national threat","authors":"Alison Knopf","doi":"10.1002/adaw.34543","DOIUrl":"https://doi.org/10.1002/adaw.34543","url":null,"abstract":"<p>Last month the Drug Enforcement Administration (DEA) released the 2025 National Drug Threat Assessment (NDTA). The report outlines the increasing challenges of the fentanyl crisis. The adulterating of fentanyl with highly potent, dangerous chemicals reminds us that this fight is far from over,” said DEA Acting Administrator Robert Murphy. “DEA and our federal, state, and local law enforcement partners must continue to adapt and work together to attack global drug trafficking organizations at every level. By joining forces to reduce supply and demand, we can destroy the drug trafficking networks and achieve a safer and healthier future for all Americans.”</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171905","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"House votes for reconciliation bill by 215-214 vote","authors":"Alison Knopf","doi":"10.1002/adaw.34542","DOIUrl":"https://doi.org/10.1002/adaw.34542","url":null,"abstract":"<p>It's more bad news for people who need Medicaid, with the House of Representatives voting May 22 to approve the “One Big Beautiful Bill Act” (H.R. 1) by a 215-to-214 vote. Only two Republicans voted no. The focus is now on the Senate. The vote occurred at 1:00 in the morning. The bill makes permanent the tax cuts approved in 2017, and extends them to equal about $4 trillion. The proposed legislation also reduces federal spending by approximately $1.5 trillion over 10 years, increase the debt limit; and provide an estimated $300 billion for border security and defense.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Study of prevalence and costs of OUD","authors":"Alison Knopf","doi":"10.1002/adaw.34537","DOIUrl":"https://doi.org/10.1002/adaw.34537","url":null,"abstract":"<p>Last month Avalere Health released a report totaling the costs of opioid use disorder (OUD) and the impact of treatment in limiting those costs. The study, supported by Indivior, found that the average case of OUD costs $695,000 a year, most of which goes to the criminal justice system. Treatment, however, lowers those costs. The study focuses on the benefits of long-acting injectable buprenorphine, made by Indivior, which was found to be more cost-effective than sublingual buprenorphine or methadone.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"In Case You Haven't Heard…","authors":"","doi":"10.1002/adaw.34545","DOIUrl":"https://doi.org/10.1002/adaw.34545","url":null,"abstract":"<p>“We're probably going to stop publishing in the <i>Lancet</i>, <i>New England Journal of Medicine</i>, <i>JAMA</i> and those other journals, because they're all corrupt.” Robert F. Kennedy Jr., Secretary of the Department of Health and Human Services (HHS), proclaimed this last week. He accused the journals of being supported by pharmaceutical companies. The “we” is the federal government. This would include researchers from the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"NAATP takes steps to simplify reporting of marketing misdeeds","authors":"Gary Enos","doi":"10.1002/adaw.34538","DOIUrl":"https://doi.org/10.1002/adaw.34538","url":null,"abstract":"<p>In an addiction treatment marketplace that historically has been characterized as a Wild West, it often has been easier to uncover deceptive or fraudulent marketing practices than to see something concrete done about them. Leaders at last month's annual conference of the National Association of Addiction Treatment Providers (NAATP) assured attendees that they are taking steps to simplify the effort to report practices that damage a provider's brand and mislead patients.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"1-8"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Buprenorphine in pregnancy improves health of mom and newborn","authors":"Alison Knopf","doi":"10.1002/adaw.34539","DOIUrl":"https://doi.org/10.1002/adaw.34539","url":null,"abstract":"<p>Opioid use disorder (OUD) in pregnancy is a serious problem, but buprenorphine and methadone, medications which treat the disorder, both improve outcomes for mothers and their children. Researchers conducted a retrospective cohort study of Medicaid Tennessee pregnant patients, and found buprenorphine compared to no treatment improved outcomes. For the study, “Buprenorphine Treatment in Pregnancy and Maternal-Infant Outcomes,” published in <i>JAMA Health Forum</i> April 27, the researchers followed 14,463 maternal-infant dyads continuously enrolled in the Tennessee Medicaid program from 20 weeks' estimated gestational age to 6 weeks post-partum between 2010 and 2021.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"4-6"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"It is not just opioids!","authors":"Robert Kent","doi":"10.1002/adaw.34540","DOIUrl":"https://doi.org/10.1002/adaw.34540","url":null,"abstract":"<p>When I worked at the NYS Office of Addiction Services and Supports (OASAS), Commissioner Arlene Gonzalez-Sanchez would regularly remind me that our addiction care programs help individuals with addictions and not the substances they use. For the last two decades we have focused much of our energy on treating opioids, and we needed to do this.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Psychosis and cannabis use linked, but is dopamine involved?","authors":"Alison Knopf","doi":"10.1002/adaw.34541","DOIUrl":"https://doi.org/10.1002/adaw.34541","url":null,"abstract":"<p>In a small study, researchers observed a possible link based on magnetic resonance imaging (MRI) between elevated dopamine function, cannabis use, and schizophrenia. It is known that cannabis use is linked to psychosis, and dopamine is linked to psychosis, but whether there is a dopamine link is unclear.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 22","pages":"6-7"},"PeriodicalIF":0.0,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144171903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"“Move Upstream”","authors":"Robert Kent","doi":"10.1002/adaw.34532","DOIUrl":"https://doi.org/10.1002/adaw.34532","url":null,"abstract":"<p>As many continue celebrate, and take credit for, the reduction in overdose deaths in the last year; no one focuses much attention on how many non-fatal overdoses occur annually.</p>","PeriodicalId":100073,"journal":{"name":"Alcoholism & Drug Abuse Weekly","volume":"37 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144125904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}